The National Pharmaceutical Council (NPC) in a recent study published in JAMA suggests including productivity in value assessments can have a noticeable impact. Taruja Karmarkar, NPC/Duke-Margolis health policy fellow, discusses the study in a blog post published on NPC. "We found that […]
Panel Discusses How Pandemic Might Impact Value of Innovation
A panel discussion during the eyeforpharma Virtual Conference discussed how the pandemic might impact the value of innovation, productivity and preparedness. National Pharmaceutical Council (NPC) CSO Robert Dubois moderated the discussion, which featured Biogen Senior Vice President of Value and […]
NPC’s Leonard Outlines Findings of Research on Coverage Decisions
National Pharmaceutical Council President and CEO Dan Leonard in a recent write up published on Pharmacy Times outlines some key findings of research by NPC and CEVR on coverage decisions by insurers. A joint study published by the pair in 2018, Leonard writes, found that "insurance coverage and […]
Blog Post: Making the Most of Our Health Care Dollars
A recent blog post on Going Below the Surface highlights a panel discussion during AcademyHealth National Health Policy Conference that focused on more effective health care spending. The panel, which was moderated by National Pharmaceutical Council CSO Robert Dubois, featured: Stacie […]
NPC Study: Measurement Standards Needed to Assess Direct, Indirect Benefits of Therapies
While therapies capable of mental and physical improvements can see both direct and indirect benefits, measurement standards are necessary to adequately assess those benefits, the National Pharmaceutical Council suggests in a new study. NPC surveyed U.S. providers, pharmacy benefit managers, […]
NPC Webinar to Spotlight Evidence-Based Health Coverage
The National Pharmaceutical Council (NPC) is slated to host a webinar noon EST Feb. 13 highlighting evidence-based coverage decisions by health plans. Featured presenters include NPC's Jennifer Graff, Tufts Medical Center's James Chambers, Benfield's Scott Thompson and Florida Association Health […]
NPC’s Leonard Outlines ‘Wish List’ for Health Sector
National Pharmaceutical Council President and CEO Dan Leonard in an article published on Chain Drug Review outlines his wish list for the health care sector. The first step, Leonard writes, is to "have an honest and open dialogue about the many drivers of health care spending and costs." "We […]
SWHR’s Kocsis: Women Matter in Value Assessments
The National Pharmaceutical Council (NPC) recently sat down with the Society for Women's Health Research (SWHR) Vice President of Public Policy Sarah Kocsis to discuss the society's thinking on value assessments. Kocsis also discussed what the society hopes to see during the Institute for […]
Webinar Spotlights Low-Value Care
A Jan. 15 webinar hosted by the Going Below the Surface Forum, in partnership with AcademyHealth and the National Pharmaceutical Council (NPC), shifted the spotlight to low-value care in the U.S., which accounts for some $340 billion in health spend. NPC CSO and Executive Vice President Robert […]
NPC: No ‘Best’ Framework for Value Assessment
The National Pharmaceutical Council (NPC) in a recent report found that out of seven value assessment frameworks, there was no "best" framework for determining a product's value. NPC Vice President for Health Services Research tells the Society for Women's Health Research that there not being a […]
